Literature DB >> 18289426

The role of hypertonic saline in neurotrauma.

H White1, D Cook, B Venkatesh.   

Abstract

Animal and human studies suggest that hypertonic saline is a potential therapeutic agent to assist with the medical treatment of patients with traumatic brain injury. It may have a place as osmotherapy to decrease brain size, predominantly of uninjured brain and has several potential advantages over mannitol. Hypertonic saline has clinically desirable physiological effects on cerebral blood flow, intracranial pressure and inflammatory responses in models of neurotrauma. Animal studies support its use, but definitive human trials using mortality end-points in brain trauma are lacking. Hypertonic saline may be considered a therapeutic adjunct to the medical management of traumatic brain injury, awaiting definitive evidence to support routine use.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18289426     DOI: 10.1017/S0265021507003420

Source DB:  PubMed          Journal:  Eur J Anaesthesiol Suppl        ISSN: 0952-1941


  5 in total

Review 1.  Blast injury research models.

Authors:  E Kirkman; S Watts; G Cooper
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-01-27       Impact factor: 6.237

Review 2.  Hypertonic saline for the treatment of intracranial hypertension.

Authors:  Tareq Kheirbek; Jose L Pascual
Journal:  Curr Neurol Neurosci Rep       Date:  2014-09       Impact factor: 5.081

3.  Single bolus 30% hypertonic saline for refractory intracranial hypertension.

Authors:  E H Major; P O'Connor; B Mullan
Journal:  Ir J Med Sci       Date:  2014-02-15       Impact factor: 1.568

4.  Comparison of 7.2% hypertonic saline - 6% hydroxyethyl starch solution and 6% hydroxyethyl starch solution after the induction of anesthesia in patients undergoing elective neurosurgical procedures.

Authors:  Liujiazi Shao; Baoguo Wang; Shuangyan Wang; Feng Mu; Ke Gu
Journal:  Clinics (Sao Paulo)       Date:  2013       Impact factor: 2.365

5.  Hypertonic saline reduces lipopolysaccharide-induced mouse brain edema through inhibiting aquaporin 4 expression.

Authors:  C Cao; X Yu; Z Liao; N Zhu; H Huo; M Wang; G Ji; H She; Z Luo; S Yue
Journal:  Crit Care       Date:  2012-10-04       Impact factor: 9.097

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.